Patent holdings for IPC class A61K 31/4741

Total number of patents in this class: 493

10-year publication summary

48
21
30
39
33
45
25
43
36
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
The United States of America, as represented by the Secretary, Department of Health and Human Services
2838
17
H4 Orphan Pharma
10
10
The Regents of the University of California
19839
9
Purdue Research Foundation
3571
8
Florida State University Research Foundation, Inc.
732
8
Gilead Sciences, Inc.
2027
8
Eli Lilly and Company
3825
7
Shanghai Hengrui Pharmaceutical Co., Ltd.
630
7
vTv Therapeutics LLC
152
7
The Trustees of the University of Pennsylvania
4315
6
CBA Pharma, Inc.
14
6
Jiangsu Hengrui Medicine Co., Ltd.
706
6
Trustees of Boston University
973
6
H. Lundbeck A/S
1228
6
Algernon Pharmaceuticals Inc.
23
6
Boehringer Ingelheim International GmbH
4698
5
Arbutus Biopharma Corporation
177
5
Emory University
1622
5
Mitotech SA
31
5
BASF SE
20803
4
Other owners 352